===
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons
closely associated with them
26.06.2024 / 13:12 CET/CEST
The issuer is solely responsible for the content of this announcement.
1. Details of the person discharging managerial responsibilities / person closely associated
a) Name


Title: Dr.

First name: Ulrich

Last name(s): Köstlin
2. Reason for the notification a) Position / status


Position: Member of the administrative or supervisory body
b) Initial notification 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name


Newron Pharmaceuticals S.p.A.
b) LEI


8156002F8C11F80A9740
4. Details of the transaction(s) a) Description of the financial instrument, type of instrument, identification code


Type: Share

ISIN: IT0004147952
b) Nature of the transaction


Acquisition
c) Price(s) and volume(s)


Price(s) Volume(s)

9.8 CHF 10535.0 CHF
d) Aggregated information


Price Aggregated volume

9.8000 CHF 10535.0000 CHF
e) Date of the transaction


25/06/2024; UTC+2
f) Place of the transaction


Name: Swiss Exchange

MIC: XSWX

===
-----------------------------------------------------------------------------------------------------------------------

26.06.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com

-----------------------------------------------------------------------------------------------------------------------

===

Language:     English 
Company:      Newron Pharmaceuticals S.p.A. 

via Antonio Meucci 3
20091 Bresso
Italy
Internet: www.newron.com

End of News EQS News Service
===
92695 26.06.2024 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1933767&application_name=news

END) Dow Jones Newswires

June 26, 2024 07:12 ET (11:12 GMT)